HAP Trading’s Guardant Health GH Stock Holding History

HAP Trading’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,438	Closed	-$955K	–	1376
2022 Q4	$910K	Buy	+33,438	New	+$1.53M	0.09%	192

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HAP Trading's GH Position: Q1 2023 in Review

HAP Trading sold out of Guardant Health (GH) in Q1 2023, closing a stake of 33,438 shares — an estimated $955K sold.

HAP Trading first reported a position in GH in Q4 2022 and held it in 1 quarter. The position peaked at $910K in Q4 2022. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

HAP Trading reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
HAP Trading sold 33,438 Guardant Health shares in Q1 2023, an estimated $955K.
HAP Trading first reported a position in Guardant Health in Q4 2022 and held it in 1 quarter.
HAP Trading's Guardant Health position peaked at $910K in Q4 2022.
279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.